Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Unity Biotechnology Inc (UBX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.60 +32.67%
on 11/20/18
16.70 -7.84%
on 12/13/18
+3.11 (+25.33%)
since 11/16/18
3-Month
10.33 +48.98%
on 10/23/18
23.50 -34.51%
on 09/18/18
-7.58 (-33.00%)
since 09/17/18
52-Week
10.33 +48.98%
on 10/23/18
24.56 -37.34%
on 09/17/18
-1.26 (-7.57%)
since 05/03/18

Most Recent Stories

More News
UNITY (UBX) Soars: Stock Adds 5.1% in Session

UNITY (UBX) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

UBX : 15.28 (-3.96%)
ALXN : 110.95 (+1.39%)
UNITY Biotechnology, Inc. Appoints Margo Roberts Ph.D. to Board of Directors

UNITY Biotechnology, Inc. ("UNITY") [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced the appointment...

UBX : 15.28 (-3.96%)
UNITY Biotechnology Announces Additional Cohort to Evaluate Higher Dose in Ongoing UBX0101 Phase 1 Study in Osteoarthritis of the Knee

UNITY Biotechnology, Inc. ("UNITY") [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced that it will include...

MG.TO : 60.19 (-0.81%)
UBX : 15.28 (-3.96%)
UNITY Biotechnology, Inc. to Host Investor & Analyst Event on Cellular Senescence

- Event will be webcast live -

UBX : 15.28 (-3.96%)
UNITY Biotechnology, Inc. to Announce Third Quarter 2018 Financial Results

UNITY Biotechnology, Inc. ("UNITY") (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, plans to report results for the...

UBX : 15.28 (-3.96%)
UNITY Biotechnology, Inc. to Participate in the Cantor Fitzgerald Annual Global Healthcare Conference

UNITY Biotechnology, Inc. ("UNITY") (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced that Bob Goeltz,...

UBX : 15.28 (-3.96%)
Today's Research Reports on Stocks to Watch: Unity Biotechnology and Principia Biopharma

NEW YORK, NY / ACCESSWIRE / September 17, 2018 / Biotech stocks Unity Biotechnology and Principia Biopharma had exciting trading days on Friday. Shares of Unity saw more gains on Friday after exploding...

PRNB : 28.96 (+1.08%)
UBX : 15.28 (-3.96%)
Unity (UBX) Catches Eye: Stock Jumps 8.8%

Unity (UBX) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.

UBX : 15.28 (-3.96%)
GILD : 65.46 (-0.17%)
UNITY Biotechnology, Inc. to Participate in the Morgan Stanley 16th Annual Global Healthcare Conference

UNITY Biotechnology, Inc. ("UNITY") (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced that Keith Leonard,...

MS : 39.80 (+0.40%)
UBX : 15.28 (-3.96%)
UNITY Biotechnology, Inc. Announces Closing of Initial Public Offering

UNITY Biotechnology, Inc. ("UNITY") (NASDAQ:UBX) today announced the closing of the Company's initial public offering of 5,000,000 shares of common stock at a public offering price of $17.00 per share,...

MS : 39.80 (+0.40%)
UBX : 15.28 (-3.96%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar